Atherosclerosis is a complex disease associated with aberrant lipoprotein metabolism and leukocytic infiltration into arterial tissue [1] . Although it is widely appreciated that macrophages are a critical contributor in the crosstalk between disorders of lipoprotein metabolism and innate immunity responses, there are also complex roles of T lymphocytes evoking adaptive immune responses within lesions [2] .
Apolipoprotein E (apoE) À/À and LDL receptor À/À mice are commonly used to define mechanisms of atherosclerosis. To understand the contribution of their divergent lipoprotein characteristics to atherosclerosis, Parks et al. [3 ] studied G2A, a lysophospholipid-sensitive G protein-coupled receptor that is abundantly expressed by macrophages and endothelial cells [4, 5] . Both proatherogenic and antiatherogenic effects have been ascribed to G2A [4,5] . To resolve this conundrum of contradictory effects, Parks et al.
[3 ] performed comprehensive atherosclerosis studies in mice with single or compound deficiency of apoE and LDL receptor. They found that G2A regulated HDL cholesterol concentrations only in the presence of apoE. Furthermore, deletion of G2A in mice with apoE deficiency or compound deficiency of apoE and LDL receptor had either no or augmented effects on atherosclerosis [3 ] . In contrast, G2A deficiency reduced atherosclerosis in LDL receptor À/À mice [5] . However, chimeric LDL receptor À/À mice with G2A deficiency in bone marrow-derived cells had no effect on plasma HDL cholesterol concentrations and failed to ameliorate atherosclerosis. Although this finding indicates a critical role of G2A in resident tissues, cell-specific manipulation of G2A will be needed to define the mechanistic basis for the apoE-dependent modulation of HDL and atherosclerosis.
Cholesterol loading of macrophages stimulates a series of inflammatory mediators to promote atherosclerosis. Recent attention has focused on mannose-binding lectin (MBL). Studies [6, 7] using humans provided conflicting findings with either proatherogenic or antiatherogenic effects of MBL. To unravel this dilemma, Matthijsen et al.
[8 ] studied the development of atherosclerosis in LDL receptor À/À mice. Interestingly, MBL was abundant in macrophage-rich atherosclerotic lesions from mice fed a fat-enriched diet for 10 weeks but was only expressed in necrotic cores of lesions in mice fed the same diet for 18 weeks. Bone marrow transplantation demonstrated that macrophage-expressed MBL was the dominant source influencing atherosclerosis. However, this was only studied in mice fed the fat-enriched diet for 10 weeks. It would also be interesting to determine whether MBL deficiency in macrophages changes atherosclerosis in these mice after an 18-week high-fat diet feeding because MBL was not present in macrophages in more advanced lesions.
As noted above, T lymphocytes are present in atherosclerotic lesions and have a complex role in lesion development [9] . Collective evidence shows that hypoxiainducible factor-1a (HIF-1a), the oxygen-dependent transcriptional regulator, downregulates T helper 1 (Th1) programs while propagating T helper 2 (Th2) responses [10] . In spite of the potential role of HIF-1a, no atherosclerosis studies had been performed. To fill this void in knowledge, Ben-Shoshan et al. [11 ] performed an atherosclerosis study in apoE À/À mice that were intravenously administered plasmids containing either no gene or HIF-1a. Robust expression of HIF-1a was evident in mouse spleen, accompanied by large increases in plasma concentrations of IL-10 and a corresponding decrease of IFNg. A profound reduction of atherosclerosis was detected in mice injected with the HIF-1a plasmid. Interestingly, IFNg was not only suppressed in CD4 þ spleen-derived lymphocytes, but also diminished in atherosclerotic lesions in these HIF-1a-expressing mice. IFNg is expressed by both macrophages and T lymphocytes, but the main cell type expressing this cytokine was not defined in this study. This study is consistent with the literature demonstrating that an enhancement of Th2 responses has the beneficial effect of reducing atherosclerosis.
These recent animal studies further attempt to clarify some of the complexities in the literature regarding the interactions of lipoprotein metabolism and leukocytes in the development of atherosclerosis. This clarity will be required for the extrapolation of these data to the human disease. However, irrespective of the contradictions, it is clear that macrophages, lymphocytes and their consequent immune responses have important roles in atherosclerosis.
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